See also this year's filing and all EDGAR filings for this company.
PDF Report 0001124608_2013_Response_Genetics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Myriad Genetics INC', 'shared_tokens': {'genetics'}}, {'other_company': 'Interleukin Genetics INC', 'shared_tokens': {'genetics'}}]} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001124608')"} |
Graph
Absolute values for 0001124608, Response Genetics INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 5,271,797 |
| 2 | remainder_Liabilities | 83,910 |
| 3 | AssetsCurrent | 14,990,613 |
| 4 | AssetsNoncurrent | 0 |
| 5 | PropertyPlantAndEquipmentNet | 1,023,198 |
| 6 | Goodwill | 575,409 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 24,265,325 |
| 9 | ResearchAndDevelopmentExpense | 2,128,610 |
| 10 | remainder_Expenses | 85,838 |
| 11 | remainder_Revenues | 18,736,669 |
| 12 | remainder_NetIncome | -13,975 |
| 13 | remainder_ComprehensiveNetIncome | 3,180 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 5,355,707 |
| 1 | Assets | 16,589,220 |
| 2 | Expenses | 26,479,773 |
| 3 | Revenues | 18,736,669 |
| 4 | StockholdersEquity | 11,233,513 |
| 5 | NetIncome | -7,757,079 |
| 6 | ComprehensiveNetIncome | -7,755,489 |
| 7 | BaseVar | 33,589,262 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.696 |
| 9 | EconomicCapitalRatio | 1.46 |